Ocular myasthenia gravis in a senior population: Diagnosis, therapy, and prognosis

  title={Ocular myasthenia gravis in a senior population: Diagnosis, therapy, and prognosis},
  author={J. A. Allen and S. Scala and H. Jones},
  journal={Muscle & Nerve},
  • J. A. Allen, S. Scala, H. Jones
  • Published 2010
  • Medicine
  • Muscle & Nerve
  • The objectives of this study were (I) to explore the prognosis of ocular myasthenia gravis (OMG) in patients with onset at age 70 years and above (i.e. senior persons); (2) to identify predictors of secondary generalization in this age group; and 3) to address the effects of immunotherapy on this population of patients. We performed a retrospective analysis of 39 patients with myasthenia gravis who presented with only ocular signs and symptoms after age 70 years. Generalized myasthenia gravis… CONTINUE READING
    31 Citations
    Factors affecting outcome in ocular myasthenia gravis
    • 20
    Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China


    Myasthenia gravis with ocular involvement in older patients.
    • 12
    • Highly Influential
    Myasthenia gravis in the elderly: a hospital based study
    • 31
    • Highly Influential
    Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    • 147
    • Highly Influential
    • PDF
    Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    • 159
    • PDF
    Immunotherapy of Ocular Myasthenia Gravis Reduces Conversion to Generalized Myasthenia Gravis
    • 86
    The relationship of age to outcome in myasthenia gravis
    • 98
    Prognosis of ocular myasthenia
    • 175
    • Highly Influential
    The Course of Myasthenia Gravis and Therapies Affecting Outcome a
    • 282
    • Highly Influential